DOI: 10.1055/s-00000142

Frauenheilkunde up2date


Rastogi P, Buyse ME, Swain SM et al.
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.

Clin Breast Cancer 2011;
11: 228-234

Download Bibliographical Data